[1] |
Pabinger I,van Es N,Heinze G, et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts[J]. Lancet Haematol, 2018, 5(7): e289-e298.
|
[2] |
Higginson J.International Agency for Research on Cancer[J]. Arch Pathol, 1974, 98(5): 289-291.
|
[3] |
Lee KW,Bang SM,Kim S, et al. The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer[J]. J Thromb Haemost, 2010, 8(3): 540-547.
|
[4] |
Lyman GH,Khorana AA,Falanga A, et al.American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer[J]. J Clin Oncol, 2007, 25(34): 5490-5505.
|
[5] |
Aleman MM,Byrnes JR,Wang JG, et al. Factor XIII activity mediates red blood cell retention in venous thrombi[J]. J Clin Invest, 2014, 124(8): 3590-3600.
|
[6] |
Van Der Meijden, PE,Van Schifgaarde M,Van Oerle R, et al. Platelet and erythrocytederived microparticles trigger thrombin generation via factor XIIa[J]. J Thromb Haemost, 2012, 10(7): 1355-1362.
|
[7] |
Cai FQ,Jing YH,Gao YF, et al. [Immune adherence(C3b) receptor activity of erythrocytes in patients with esophageal cancer and cancer of the gastric cardia][J]. Zhonghua Zhong Liu Za Zhi, 1986, 8(4): 253-255.
|
[8] |
何晓凤,李秋.血小板相关抗体及膜糖蛋白在胃癌患者中的临床检测意义探析[J].中国实验诊断学,2018,22(7): 1174-1176.
|
[9] |
Du T,Tan Z. Relationship between deep venous thrombosis and inflammatory cytokines in postoperative patients with malignant abdominal tumors[J]. Braz J Med Biol Res, 2014, 47(11): 1003-1007.
|
[10] |
Khorana AA,Kuderer NM,Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis[J]. Blood, 2008, 111(10): 4902-4907.
|
[11] |
Fuentes HE,Paz LH,Wang Y, et al. Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment[J]. Clin Appl Thromb Hemost, 2018, 24(5): 790-796.
|
[12] |
Wolberg AS,Rosndaal FR,Weitz JI, et al.Venous thrombosis[J]. Nat Rev Dis Primers, 2015, 1: 15006-15006.
|
[13] |
Semeraro F,Ammollo CT,Morrissey JH, et al.Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4[J]. Blood, 2011, 118(7): 1952-1961.
|
[14] |
Du T,Tan Z. Relationship between deep venous thrombosis and inflammatory cytokines in postoperative patients with malignant abdominal tumors[J]. Braz J Med Biol Res, 2014, 47(11): 1003-1007.
|
[15] |
Mo J,Bai B,Li Y,Deng J, et al. Expression of interleukin-18 in a rat model of deep vein thrombosis[J]. J Cardiovasc Surg (Torino), 2012, 53(5): 625-630.
|
[16] |
Lo L,Valentine H,Harrison J, et al.Tissue factor expression in the metaplasia-adenoma-carcinoma sequence of gastric cancer in a European population[J]. Br J Cancer, 2012, 107(7): 1125-1130.
|
[17] |
马玉滨,燕速,于鹏杰,等.低氧诱导因子-1α在胃癌组织中表达水平及分子作用机制研究[J].中国免疫学杂志,2017,33(12): 1799-1803.
|
[18] |
Rao B,Gao Y,Huang J, et al. Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis[J]. Int J Colorectal Dis, 2011, 26(5): 593-601.
|
[19] |
张雪,姜达,李颖.肿瘤相关性高凝的分子机制[J].国际肿瘤学杂志,2016,43(5): 356-359.
|
[20] |
Kee NL,Krause J,Blatch GL, et al. The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation[J]. Protein J, 2015, 34(5): 338-348.
|
[21] |
郭菲,黄立娟.微粒在血栓形成中的研究进展[J].国际免疫学杂志,2012,35(5): 346-349.
|
[22] |
姜璐,汪希鹏.血小板微粒相关研究进展[J].国际妇产科学杂志,2015,42(3): 306-310.
|
[23] |
Osaki T,Saito H,Fukumoto Y, et al. Risk and incidence of perioperative deep vein thrombosis in patients undergoing gastric cancer surgery[J]. Surg Today, 2018, 48(5): 525-533.
|
[24] |
严冬华,俞文渊,陈涛,等.腹腔镜及开腹远端胃癌根治术对机体凝血及免疫功能的影响分析[J].中国血液流变学杂志,2016,26(3): 346-348,369.
|
[25] |
王瑜,王燕婷,蒋彦彦,等.不同体位和不同压力的CO2气腹对腹腔镜手术患者下肢深静脉血流动力学的影响[J].中华胃肠外科杂志,2009,12(4): 361-363.
|
[26] |
赵高平,贾贵清,黎熊,等.腹腔镜辅助与常规开腹手术治疗胃癌近期疗效分析[J].中国临床研究,2016,29(7): 888-891.
|
[27] |
史枫,刘海龙,李桢,等.腹腔镜与开腹手术后下肢DVT发生率比较的Meta分析[J].山东医药,2015,55(10): 48-50.
|
[28] |
Abdelrazeq AS,Dwaik MA,Aldoori MI, et al.Laparoscopy-associated portal vein thrombosis: description of an evolving clinical syndrome[J]. J Laparoendosc Adv Surg Tech A, 2006, 16(1): 9-14.
|
[29] |
龚建军,梁亚萍,牛建华,等.不同气腹压力对腹腔镜胆囊切除术凝血-纤溶指标的影响[J].临床和实验医学杂志,2013,12(6): 420-422.
|
[30] |
段启瑞,邱颐,王彩霞.麻醉方式与药物对静脉血栓的影响及防治研究进展[J].内蒙古医科大学学报,2017,39(4): 381-385.
|
[31] |
储靖,陈宁,杨程.血栓弹力图检测5种不同液体用于术前预扩容对凝血功能的影响[J].河北医药,2013,35(9): 1348-1349.
|
[32] |
叶华,陈平,郑祺,等.胃癌术后早期应用低分子肝素对静脉血栓形成的影响[J].中华普通外科杂志,2014,29(11): 875-876.
|
[33] |
吕华新.分析肝胆外科手术患者并发下肢深静脉血栓形成的危险因素[J].中国实用医药,2013,8(8): 130-131.
|
[34] |
郜永顺,黄晶晶,陈鹏,等.胃肠外科围手术期下肢深静脉血栓形成的临床分析[J].中华普通外科杂志,2016,31(11): 940-943.
|
[35] |
龙文彬.恶性肿瘤诊疗中血液流变学检验的应用[J].医学信息,2013,26(9): 682-682.
|
[36] |
Nam SY,Ko YS,Jung J, et al. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis[J]. Br J Cancer, 2011, 104(1): 166-174.
|
[37] |
Wojtukiewicz MZ,Sierko E,Zacharski LR, et al. Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer[J]. Semin Thromb Hemost, 2003, 29(3): 291-300.
|
[38] |
张静峥,顾健.炎症体与肿瘤相关血栓形成的研究进展[J].中国实验血液学杂志,2016,24(4): 1260-1263.
|
[39] |
谭红平.胃癌患者围术期血液流变性变化的临床研究[J].现代临床医学,2011,37(4): 261-263.
|
[40] |
张少伟,刘建洛,白明辉.腹腔镜胃癌手术与开腹手术对患者凝血功能的影响[J].中国老年学杂志,2012,32(18): 4036-4037.
|